Trial Profile
Evaluation of the clinical efficacy of flutiform (fluticasone propionate /formoterol fumarate) on severe persistent bronchial asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 24 Mar 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 24 Mar 2015 New trial record